文献速递癫痫神经重症与神经感染

应用ACD评分预测癫痫持续状态后的长期生存

Prediction of Long-term Survival After Status Epilepticus Using the ACD Score.
PubMed 文献 · JAMA Neurol · 2022-01-01

这项回顾性多中心多国队列研究分析了丹麦、挪威和德国大学医院的癫痫持续状态成人患者,开发并验证了由发病年龄、入院时意识水平和癫痫持续状态持续时间组成的ACD评分,用于预测出院后2年死亡率。ACD评分与2年生存率呈线性相关(Pearson r²=0.848),尤其在脑损伤可能性低的患者亚组中。

要点

  • ACD评分由发病年龄、入院意识水平和癫痫持续状态持续时间3个因素组成,用于预测出院后2年生存。
  • 新发神经功能缺损是出院后2年生存的主要预测因素(比值比5.1;95%CI 2.2-11.8)。
  • ACD评分与2年生存率呈线性相关(Pearson r²=0.848),在脑损伤可能性低的患者中尤为明显。

核心结论

  • 年龄、长持续时间和昏迷中的非惊厥性癫痫持续状态与新发神经功能缺损相关,而新发神经功能缺损是长期死亡的预测因素。
  • 使用ACD评分考虑新发神经功能缺损的危险因素,是预测病因对大脑无损害或损害较轻的癫痫持续状态患者长期结局的可靠方法。

研究设计与样本

  • 回顾性、多中心、多国队列研究,分析丹麦欧登塞、挪威奥斯陆、德国马尔堡和法兰克福大学医院收治的18岁及以上首次非缺氧性癫痫持续状态成人患者。
  • ACD评分在丹麦队列中开发,在德国和挪威队列中验证;丹麦队列261例(平均[SD]年龄67.2[14.8]岁;女性132例[50.6%]),其中145例病因对大脑无损害或损害较轻。
  • 验证队列包括挪威139例和德国906例患者。

主要发现

  • 出院时,29.8%的患者(64/215)较基线出现新发中度至重度神经功能缺损。
  • 新发神经功能缺损是出院后2年生存的主要预测因素(比值比5.1;95%CI 2.2-11.8),且该关联独立于病因类别。
  • 昏迷中的非惊厥性癫痫持续状态和癫痫持续状态持续时间与新发神经功能缺损的发展相关。
  • ACD评分与2年生存率呈线性相关(Pearson r²=0.848),尤其在脑损伤可能性低的患者亚组中。

关键数值与推荐

  • ACD评分包含发病年龄、入院时意识水平和癫痫持续状态持续时间3个因素。
  • 新发神经功能缺损预测2年生存的比值比为5.1(95%CI 2.2-11.8)。
  • ACD评分与2年生存率的线性相关系数为Pearson r²=0.848。

临床怎么用

  • 作者认为,使用ACD评分考虑新发神经功能缺损的危险因素,是预测病因对大脑无损害或损害较轻的癫痫持续状态患者长期结局的可靠方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early prediction of long-term mortality in status epilepticus is important given the high fatality rate in the years after diagnosis. OBJECTIVE: To improve prognostication of long-term mortality after status epilepticus diagnosis. DESIGN, SETTINGS, AND PARTICIPANTS: This retrospective, multicenter, multinational cohort study analyzed adult patients who were diagnosed with and treated for status epilepticus at university hospitals in Odense, Denmark, between January 1, 2008, and December 31, 2017, as well as in Oslo, Norway; Marburg, Germany; and Frankfurt, Germany. They were aged 18 years or older and had first-time, nonanoxic status epilepticus. A new scoring system, called the ACD score, for predicting 2-year (long-term) mortality after hospital discharge for status epilepticus was developed in the Danish cohort and validated in the German and Norwegian cohorts. The ACD score represents age at onset, level of consciousness at admission, and duration of status epilepticus. Data analysis was performed between September 1, 2019, and March 31, 2020. EXPOSURES: Long-term follow-up using data from national and local civil registries in Denmark, Norway, and Germany. MAIN OUTCOMES AND MEASURES: The predefined end point was 2-year survival for all patients and for a subgroup of patients with status epilepticus causes that were not damaging or were less damaging to the brain. Neurological deficits before and after onset, demographic characteristics, etiological categories of status epilepticus, comorbidities, survival, time points, treatments, and prognostic scores for different measures were assessed. RESULTS: A total of 261 patients (mean [SD] age, 67.2 [14.8] years; 132 women [50.6%]) were included, of whom 145 patients (mean [SD] age, 66.3 [15.0] years; 78 women [53.8%]) had status epilepticus causes that were not damaging or were less damaging to the brain. The validation cohort comprised patients from Norway (n = 139) and Germany (n = 906). At hospital discharge, 29.8% of patients (n = 64 of 215) had new moderate to severe neurological deficits compared with baseline. New neurological deficits were a major predictor of 2-year survival after hospital discharge (odds ratio, 5.1; 95% CI, 2.2-11.8); this association was independent of etiological category. Nonconvulsive status epilepticus in coma and duration of status epilepticus were associated with development of new neurological deficits, and a simple 3-factor score (ACD score) combining these 2 risk factors with age at onset was developed to estimate survival after status epilepticus diagnosis. The ACD score had a linear correlation with 2-year survival (Pearson r2 = 0.848), especially in the subset of patients with a low likelihood of brain damage. CONCLUSIONS AND RELEVANCE: This study found that age, long duration, and nonconvulsive type of status epilepticus in coma were associated with the development of new neurological deficits, which were predictors of long-term mortality. Accounting for risk factors for new neurological deficits using the ACD score is a reliable method of prediction of long-term outcome in patients with status epilepticus causes that were not damaging or were less damaging to the brain.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Roberg LE, Monsson O, Kristensen SB, et al. Prediction of Long-term Survival After Status Epilepticus Using the ACD Score. JAMA Neurol. 2022. PMID: 35404392. doi:10.1001/jamaneurol.2022.0609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。